You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company aims to use the methylation technology from its multi-cancer screening assay to detect minimal residual disease in early-stage cancer patients.
Monozygotic twins differ on average by 5.2 early developmental mutations, and about 15 percent of them have a large number of mutational differences.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins.
The genome-wide association study, conducted by a DeCode Genetics-led team, further uncovered variants influencing the perception of licorice and cinnamon smells.
The newly public company has attracted attention from both investors and competitors for its technology platform used in antibody discovery workflows.
SomaLogic will analyze more than 40,000 samples, including from Amgen clinical trials, using its SomaScan platform, which measures up to 5,000 proteins.
The findings underscore the value of carrying out large-scale human genetic analyses as part of drug target identification and validation efforts.
The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.
The team also found that the proportion of infected people didn't change substantially during the screening period, consistent with beneficial containment.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.